Meeting on the Med 2021 | Shaping the future of CMC in cell & gene therapy

Stephen Ward, PhD, Cell and Gene Therapy Catapult, London, UK, provides an overview of the current Chemistry, Manufacturing and Controls (CMC) landscape in the cell and gene therapy industry and outcomes from a panel discussion on CMC at Cell & Gene Meeting on the Mediterranean 2021. He describes some of the important considerations and recommendations for developers that were discussed, including early investment in CMC, a focus on product characterization at an early stage and the utilization of platforms and technologies to build a pathway toward scalability. This interview took place during the Cell & Gene Meeting on the Mediterranean 2021 virtual conference.